Nanoco Group PLC Director/PDMR Shareholding (3699E)

TIDMNANO

RNS Number : 3699E

Nanoco Group PLC

17 October 2018

17 October 2018

NANOCO GROUP PLC

("Nanoco", the "Group", or the "Company")

Director/PDMR Shareholding

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, has been notified that Alison Fielding, a Non-Executive Director of the Group acquired Ordinary shares in the Company as set out below.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 
 1  Details of the person discharging managerial responsibilities/person closely associated 
a)  Name                                                         Alison Fielding 
2   Reason for the notification Purchase of Ordinary Shares 
a)  Position/status                                              Non-Executive Director 
b)  Initial notification/Amendment                               Initial notification 
3   Details of the issuer, emission allowance market participant, auction platform, auctioneer 
     or auction monitor 
a)  Name                                                         Nanoco Group plc 
b)  LEI                                                          England & Wales Company Number: 05067291 
4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
     each type of transaction; (iii) each date; and (iv) each place where transactions have been 
     conducted 
a)  Description of the financial instrument, type of instrument  Ordinary Shares 
    Identification code                                          NANO 
                                                                  ISIN GB00B01JLR99 
b)  Nature of the transaction                                    Acquisition of Ordinary Shares 
c)  Price(s) and volume(s)                                       Price(s) 34.4p 
                                                                  Volume(s) 43,566 
d)  Aggregated information                                       Price(s) 34.4p 
                                                                  Volume(s) 43,566 
e)  Date of transaction                                          17 October 2018 
f)  Place of transaction                                         London Stock Exchange 
 

For further information, please contact:

 
 Nanoco                                Tel: [phone] 
 Michael Edelman, Chief Executive 
  Officer 
 Brian Tenner, Chief Operating and 
  Financial Officer 
 Caroline Watson, Investor Relations   Tel: + 44 (0) 7799 897357 
  Manager 
 [e-mail] 
 
 Peel Hunt                             Tel: [phone] 
 Adrian Trimmings 
 George Sellar 
 Guy Pengelley 
 
 MHP Communications                    Tel: [phone] 
 Reg Hoare / Giles Robinson / Peter 
  Lambie 
 [e-mail] 
 
 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD(R) quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHFKODQBBDDAKD

(END) Dow Jones Newswires

October 17, 2018 08:47 ET (12:47 GMT)